PTX3 and breast carcinoma: reported that doxorubicin chemotherapy upregulated both the PTX3 protein cargo in EVs and the secretion of EVs from breast cancer cells, finally resulting in the lung metastasis of breast cancer by priming the PMN (Wills et al., 2021).